Telehealth: the transition to routine care is necessary but far from being achieved
Following the SNITEM meeting on Thursday, September 16, various feedbacks were proposed, including those of start-ups BiOSENCY, Kelindi and myDiabby HealthCare, on digital solutions that allow to monitor, diagnose, and treat diabetes, heart failure and lung cancer, or respiratory failure.
A round table discussion on "Digital solutions: when and how to finally move into routine" closed this meeting with Lucile Blaise, Vice-President Western Europe of Resmed, Fabrice Denis, co-founder "Kelindi e-santé / IA UFR de médecine de Paris centre", Yann Mael Le Douarin, medical advisor for telemedicine at the DGOS, Jean-Paul Ortiz, President of the CSMF and Jean-François Thébaut, Vice President of the Diabetes French Federation.
In conclusion of these various discussions, several points stand out:
- The health crisis has led to an "unprecedented acceleration" and an "awareness of the value of digital health."
- Teleconsultation worked well because doctors had easy-to-use tools and were paid for their usual activities.
- As for telemonitoring, the public authorities are committed to making it part of common law by 2022.
- As a reminder, the Etapes program (Telemedicine experiments for the improvement of health care pathways) ends on January 1, 2022. This measure could be included in the next Social Security Financing Bill (PLFSS) for 2022, which will be debated in the fall.
- Three elements are necessary to allow remote monitoring enter routine care: "to have adapted tools and software; a remote monitoring act, which is a structuring element to finance the organizations and will allow to take care of several thousands of patients, to create a new care pathway; and an evaluation in real life."
Please, do not hesitate to contact us should you have any question.